Alada? M.Kantarçeken B.Karincao?lu M.Sertkaya A.Çikim K.Harputluo?lu M.M.M.Demirel U.2024-08-042024-08-0420051300-4948https://hdl.handle.net/11616/91220[No abstract available]eninfo:eu-repo/semantics/closedAccessamoxicillinclarithromycinomeprazolepantoprazolebacterial infectionclinical trialdemographyduodenum ulcerHelicobacter pylorihumanletterulcer healing2-PyridinylmethylsulfinylbenzimidazolesAdolescentAdultAmoxicillinAnti-Bacterial AgentsAnti-Ulcer AgentsClarithromycinDrug Therapy, CombinationDuodenal UlcerFemaleH(+)-K(+)-Exchanging ATPaseHelicobacter InfectionsHelicobacter pyloriHumansMaleMiddle AgedOmeprazoleRandomized Controlled TrialsRandomized Controlled Trials as TopicTreatment OutcomeComparison of pantoprazole- Vs. omeprazole- based triple therapy regimens in the treatment of Helicobacter pylori infection and duodenal ulcer healing in a Turkish population [2]Letter164242243165478582-s2.0-33144461094Q3